Twist Bioscience reported solid Q1 FY25 results, although this was insufficient to drive the company's share price higher. The demand environment remains challenging, and Trump's election has ...

In this article, we are going to take a look at where Twist Bioscience Corporation (NASDAQ:TWST) stands against the other stocks in Cathie Wood’s portfolio. Cathie Wood is one of Wall Street’s ...

TWIST BIOSCIENCE ($TWST) is expected to release its quarterly earnings data on Monday, February 3rd before market open. Analysts are expecting revenue of $88,712,460 ...

Barclays analyst Luke Sergott maintained a Buy rating on Twist Bioscience (TWST – Research Report) today and set a price target of $52.00. The company’s shares closed last Friday at $52.37.

In a report released today, Rachel Vatnsdal from J.P. Morgan maintained a Sell rating on Twist Bioscience (TWST – Research Report), with a price target of $40.00. The company’s shares closed ...

Ratings for Twist Bioscience TWST were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ratings ...

Twist Bioscience (TWST) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

Twist Bioscience Corporation (NASDAQ:TWST), a player in the U.S. Life Science Tools & Diagnostics sector, has been making strides in operational efficiency and product development. This comprehensive ...